🇺🇸 FDA
Patent

US 7119064

Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules

granted A61KA61K38/06A61K38/07

Quick answer

US patent 7119064 (Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules) held by The Board of Regents of the University of Texas System expires Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 10 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/06, A61K38/07, A61K38/08, A61K38/10